In yesterday’s Wall Street session, Clarivate Plc (NYSE:CLVT) shares traded at $7.35, down -2.00% from the previous session.
CLVT stock price is now -7.74% away from the 50-day moving average and -7.16% away from the 200-day moving average. The market capitalization of the company currently stands at $4.90B.
With the price target maintained at $8, Wells Fargo recently Downgraded its rating from Equal Weight to Underweight for Clarivate Plc (NYSE: CLVT). On October 16, 2023, Jefferies Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock reducing its target price from $10 to quote $8.50, while ‘Barclays’ rates the stock as ‘Underweight’
A total of 44.57% of the company’s stock is owned by insiders.
During the past 12 months, Clarivate Plc has had a low of $6.07 and a high of $10.03. As of last week, the company has a debt-to-equity ratio of 0.80, a current ratio of 0.91, and a quick ratio of 0.91. The fifty day moving average price for CLVT is $7.93 and a two-hundred day moving average price translates $7.91 for the stock.
The latest earnings results from Clarivate Plc (NYSE: CLVT) was released for Dec, 2023. According to the Information Technology Services Company, earnings per share came in at $0.23, beating analysts’ expectations of $0.21 by 0.02. This compares to $0.51 EPS in the same period last year. The net profit margin was -37.53% and return on equity was -14.23% for CLVT. The company reported revenue of $683.7 million for the quarter, compared to $675.3 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 1.24 percent. For the current quarter, analysts expect CLVT to generate $618.83M in revenue.
Clarivate Plc(CLVT) Company Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
